Medication info

Plasmalight 148

Prescription medicationInjectionsIntravenous injection
Ingredient · strength
Sodium Chloride›526mg / 100mLPotassium Chloride›37mg / 100mLMagnesium Chloride Hydrate›30mg / 100mLSodium Acetate Hydrate›368mg / 100mLSodium Gluconate›502mg / 100mL
Manufacturer / importer
.
Appearance
A colorless, transparent liquid filled in plastic container for infusion.
Packaging
500ml/bag, 1000ml/bag
Approval status
Active

MFDS item code 201302424 · Notified 2013.01.28 · Insurance code 078200110

Summary

Main use
Replacement and correction of extracellular fluid; improvement of metabolic acidosis
Who receives it
Adults
Adult administration
Usually, 500~1,000mL is administered to adults by intravenous drip infusion. The infusion rate is 200mL per hour. The dose, infusion rate, and duration of administration should be adjusted appropriately according to the purpose of use, age, body weight, concomitant treatment, clinical symptoms, and laboratory test results.

Ingredients

Importer
.

Efficacy & effects

Replacement and correction of extracellular fluid; improvement of metabolic acidosis

View approved original text

This injection helps replenish and normalize extracellular fluid when the circulating blood volume and body fluid between tissues have decreased. It is also used to improve a condition of excess acidic substances known as metabolic acidosis. Through these effects, it is effective in the treatment that supports the body's fluid balance and acid regulation.

How it is given

Adult administration

Usually, 500~1,000mL is administered to adults by intravenous drip infusion. The infusion rate is 200mL per hour. The dose, infusion rate, and duration of administration should be adjusted appropriately according to the purpose of use, age, body weight, concomitant treatment, clinical symptoms, and laboratory test results.

Precautions

This medication is not suitable as the primary treatment for severe metabolic acidosis. It is also advised not to use it for the treatment of hypomagnesemia or severe potassium deficiency. When administering this medication, hypersensitivity reactions such as anaphylaxis may occur, so if symptoms appear, administration should be stopped immediately and appropriate treatment must be received. Patients at risk of hyperkalemia, especially those with poor kidney function or heart disease, should not use this medication; if unavoidable, potassium levels in the blood must be carefully monitored. Hypernatremia, hyperchloremia, and fluid overload may occur; therefore, caution should be taken when administering to patients at risk of these conditions, and regular monitoring of serum sodium and chloride levels, acid-base balance, and kidney function is necessary. Special attention should be given to children, elderly patients, post-operative patients, or patients on certain medications when administering this drug due to the high risk of hyponatremia, and immediate action should be taken if symptoms of hyponatremia occur. This medication contains sodium and potassium; thus, using it in conjunction with potassium-sparing diuretics or ACE inhibitors increases the risk of hyperkalemia, necessitating careful management of drug interactions. Women who are pregnant or breastfeeding should use this medication only after consultation with a doctor, as safety has not been established. Safety and efficacy in children have not been sufficiently proven; therefore, careful use while closely monitoring serum electrolyte levels is required. In case of overdose, metabolic alkalosis, hyperkalemia, hypermagnesemia, and fluid overload may occur, requiring immediate medical intervention. Before administration, check for turbidity or discoloration of the solution, ensure compatibility when mixing additives, and do not reuse any remaining solution after use. This medication can affect various electrolyte imbalances and fluid status, so it is important to regularly monitor blood glucose, electrolytes, fluid balance, and kidney function during administration.

Side effects

  • Anaphylactic reactions
  • hypersensitivity reactions
  • infusion reactions
  • warmth at the injection site
  • infection
  • venous thromboembolism
  • phlebitis
  • exudate
  • volume overload
  • cerebral edema
Show 35 more
  • pulmonary edema
  • peripheral edema
  • metabolic alkalosis
  • tachycardia
  • palpitations
  • chest pain
  • chest discomfort
  • dyspnea
  • increased respiratory rate
  • flushing
  • congestion
  • weakness
  • mood changes
  • lip swelling
  • peripheral edema
  • fever
  • hypotension
  • wheezing
  • urticaria
  • diaphoresis
  • chills
  • pain at the infusion site
  • hyponatremia
  • hyponatremic encephalopathy
  • systemic rash
  • erythema
  • rash
  • vomiting
  • hypertension
  • hyperkalemia
  • hypernatremia
  • hyperchloremic acidosis
  • fluid overload
  • cardiac arrest
  • chills

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to prevent contact with air and kept at room temperature. Avoid storage in overly hot or cold places, and it is safest to keep it in a cool place away from direct sunlight.

Appearance and packaging

Appearance

A colorless, transparent liquid filled in plastic container for infusion.

Package unit

500ml/bag, 1000ml/bag

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.